Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2018-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/1744666X.2018.1459571PMID 29595347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Managing Advanced HIV Disease in a Public Health Approach

  2018cited by this paper
• Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs

  2018cited by this paper
• The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria

  2017cited by this paper
• Oral microbiome in HIV-associated periodontitis

  2017cited by this paper
• HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation

  2017cited by this paper
• Improving HIV post-exposure prophylaxis rates after pediatric acute sexual assault.

  2017cited by this paper
• The case for periodontitis in the pathogenesis of rheumatoid arthritis

  2017cited by this paper
• CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.

  2017influential reference
• Gut Microbiota Linked to Sexual Preference and HIV Infection

  2016cited by this paper
• Impact of periodontal intervention on local inflammation, periodontitis, and HIV outcomes.

  2016cited by this paper
• Microbial translocation and microbiome dysbiosis in HIV-associated immune activation

  2016cited by this paper
• Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals.

  2016cited by this paper
• Regulator of Calcineurin 1 in Periodontal Disease

  2016cited by this paper
• Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients

  2016cited by this paper
• Host-derived salivary biomarkers in diagnosing periodontal disease: systematic review and meta-analysis.

  2016cited by this paper
• Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression.

  2016cited by this paper
• Gut microbiota diversity predicts immune status in HIV-1 infection

  2015cited by this paper
• Bacterial invasion and persistence: critical events in the pathogenesis of periodontitis?

  2015cited by this paper
• Transcriptome analysis of bacteriophage communities in periodontal health and disease

  2015cited by this paper
• Oral health management of 97 patients living with HIV/AIDS in Ribeirão Preto, São Paulo, Brazil.

  2015cited by this paper
• Epidemiology and Relationships between CD4+ Counts and Oral Lesions among 50 Patients Infected with Human Immunodeficiency Virus

  2015cited by this paper
• Exploring salivary microbiota in AIDS patients with different periodontal statuses using 454 GS-FLX Titanium pyrosequencing

  2015cited by this paper
• Stability of antimicrobial activity of peracetic acid solutions used in the final disinfection process.

  2015cited by this paper
• [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].

  2015cited by this paper
• Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study).

  2014cited by this paper
• Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

  2014cited by this paper
• Histatins: salivary peptides with copper(II)‐ and zinc(II)‐binding motifs

  2014cited by this paper
• Human genetics shape the gut microbiome.

  2014cited by this paper
• Antibiotics and the gut microbiota.

  2014cited by this paper
• Global Metabolomic Analysis of Human Saliva and Plasma from Healthy and Diabetic Subjects, with and without Periodontal Disease

  2014cited by this paper
• Altered Oral Viral Ecology in Association with Periodontal Disease

  2014cited by this paper
• Potential contribution of saliva to the sexual transmission of HIV through the secretion of CCL20 by genital epithelial cells

  2014cited by this paper
• The mucosal immune system in the oral cavity—an orchestra of T cell diversity

  2014cited by this paper
• Exercise and associated dietary extremes impact on gut microbial diversity

  2014cited by this paper
• Influence of antiretroviral therapy and periodontal disease on human salivary beta-defensin 2 in patients infected with HIV.

  2014cited by this paper
• Effect of periodontal therapy on lactoferrin levels in gingival crevicular fluid.

  2014cited by this paper
• The association between detectable plasmatic human immunodeficiency virus (HIV) viral load and different subgingival microorganisms in Brazilian adults with HIV: a multilevel analysis.

  2014cited by this paper
• Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

  2013cited by this paper
• First Evidence of Genetic Intraspecific Variability and Occurrence of Entamoeba gingivalis in HIV(+)/AIDS

  2013cited by this paper
• Lactoferrin, a marker for periodontal disease.

  2013cited by this paper
• Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

  2013cited by this paper
• Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection.

  2013cited by this paper
• Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.

  2012cited by this paper
• The global burden of periodontal disease: towards integration with chronic disease prevention and control.

  2012cited by this paper
• Epigenetics and bacterial infections.

  2012cited by this paper
• Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients

  2012cited by this paper
• Periodontal disease in HIV/AIDS.

  2012cited by this paper
• Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?

  2012cited by this paper
• Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease

  2012cited by this paper
• HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS.

  2011cited by this paper
• Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients with Visceral Leishmaniasis

  2011cited by this paper
• Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis.

  2011cited by this paper
• HIV and bone metabolism.

  2011cited by this paper
• Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

  2011cited by this paper
• HIV infection and periodontal diseases: an overview of the post-HAART era.

  2011cited by this paper
• HIV: primary and secondary prophylaxis for opportunistic infections.

  2010cited by this paper
• Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes.

  2010cited by this paper
• Control of α4β7 Integrin Expression and CD4 T Cell Homing by the β1 Integrin Subunit

  2010cited by this paper
• Current developments in salivary diagnostics.

  2010cited by this paper
• Periodontitis, periodontopathic bacteria and lactoferrin

  2010cited by this paper
• Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

  2010cited by this paper
• Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans

  2010cited by this paper
• Tenofovir‐associated renal and bone toxicity

  2009cited by this paper
• Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

  2009cited by this paper
• Characterizing traditionally defined periodontal disease in HIV+ adults.

  2009influential reference
• The Oral Microbiota: Living with a Permanent Guest

  2009cited by this paper
• Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study.

  2009cited by this paper
• Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

  2009cited by this paper
• Lactoferrin: structure, function and applications.

  2009cited by this paper
• Salivary histatin‐5 and oral fungal colonisation in HIV+ individuals

  2009cited by this paper
• The Association Between Gingival Crevicular Fluid TGF-β1 Levels and Periodontal Status in HIV-1+ Patients

  2008cited by this paper
• HIV infection and the gastrointestinal immune system

  2008cited by this paper
• The Effect of Genital Tract Infections on HIV-1 Shedding in the Genital Tract: A Systematic Review and Meta-Analysis

  2008cited by this paper
• The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients.

  2008cited by this paper
• Increased interleukin-18 in gingival crevicular fluid from periodontitis patients.

  2008cited by this paper
• The periodontal health of homosexual men with HIV infection: a controlled study.

  2008cited by this paper
• Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil.

  2008cited by this paper
• Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study.

  2007cited by this paper
• Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis.

  2007cited by this paper
• Oral Mucosal Expression of HIV-1 Receptors, Co-receptors, and α-defensins: Tableau of Resistance or Susceptibility to HIV Infection?

  2006cited by this paper
• The many roles of chemokines and chemokine receptors in inflammation.

  2006cited by this paper
• Interleukin-6 and chronic inflammation

  2006cited by this paper
• Immunomodulatory Properties of Defensins and Cathelicidins

  2006cited by this paper
• Lactoferrin Prevents Dendritic Cell-Mediated Human Immunodeficiency Virus Type 1 Transmission by Blocking the DC-SIGN—gp120 Interaction

  2005cited by this paper
• TNFα and pathologic bone resorption

  2005cited by this paper
• Association of T CD4 lymphocyte levels and chronic periodontitis in HIV-infected brazilian patients undergoing highly active anti-retroviral therapy: clinical results.

  2005cited by this paper
• TNF-alpha and pathologic bone resorption.

  2005cited by this paper
• MINISTÉRIO DA SAÚDE Secretaria de Vigilância em Saúde Coordenação-Geral de Vigilância Ambiental em Saúde

  2004cited by this paper
• Increase in HIV Receptors/Co-receptors/α-defensins in Inflamed Human Gingiva

  2004cited by this paper
• Chemokine receptor CCR5: insights into structure, function, and regulation.

  2004influential reference
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

  2004cited by this paper
• Risk factors for periodontitis in HIV patients.

  2004influential reference
• Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva.

  2004cited by this paper
• Interactions between commensal intestinal bacteria and the immune system

  2004cited by this paper
• Osteoimmunology: interactions of the immune and skeletal systems.

  2004cited by this paper
• Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases

  2003cited by this paper
• Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication.

  2003cited by this paper
• Antimicrobial peptides in defence of the oral and respiratory tracts.

  2003cited by this paper
• Defensins in saliva and the salivary glands

  2003cited by this paper
• Human Immunodeficiency Virus Type 1 Infection and Replication in Normal Human Oral Keratinocytes

  2003cited by this paper

• Viral Contributions to Periodontal and Peri-implant Disease: A Narrative Review

  2026influential citation
• Impact of emerging and re-emerging viral infections on periodontitis progression

  2025cites this paper
• Salivary mycobiome diversity at different stages of human immunodeficiency virus infection

  2025cites this paper
• Periodontal Microbial Profiles Across Periodontal Conditions in Pediatric Subjects: A Narrative Review

  2025cites this paper
• Reducing Functional Domain of Histatin 5 Improves Antifungal Activity and Prevents Proteolytic Degradation

  2025cites this paper
• Natural and induced immune responses in oral cavity and saliva

  2025cites this paper
• Periodontal Status and Herpesiviridae, Bacteria, and Fungi in Gingivitis and Periodontitis of Systemically Compromised Pediatric Subjects: A Systematic Review

  2025cites this paper
• Human oral microbiome and its influence on mental health and brain disorders

  2025cites this paper
• Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.

  2024cites this paper
• Subgingival biofilm colonization by Candida albicans and Candida dubliniensis in patients living with HIV from Buenos Aires, Argentina

  2024cites this paper
• Antifungal peptides from living organisms

  2024cites this paper
• Necrotizing gingivitis in patients with and without HIV: a systematic literature review and meta-analysis

  2024cites this paper
• Periodontal health in a large cohort of Ugandans living with HIV: a cross-sectional study

  2024cites this paper
• Periodontal health in a large cohort of Ugandansliving with HIV: A cross-sectional study

  2024cites this paper
• Human immunodeficiency virus and oral microbiota: mutual influence on the establishment of a viral gingival reservoir in individuals under antiretroviral therapy

  2024cites this paper
• Oral Health Outcomes In An HIV Cohort With Comorbidities- Implementation Roadmap For A Longitudinal Prospective Observational Study

  2023cites this paper
• Advances in the oral microbiota and rapid detection of oral infectious diseases

  2023cites this paper
• Relevant mechanisms of MAIT cells involved in the pathogenesis of periodontitis

  2023cites this paper
• Independent Effects of HIV and Antiretroviral Therapy on the Oral Microbiome Identified by Multivariate Analyses

  2023cites this paper
• Factors Associated with Periodontitis in Patients with and without HIV

  2023influential citation
• Oral health outcomes in an HIV cohort with comorbidities- implementation roadmap for a longitudinal prospective observational study

  2023cites this paper
• Immune indices and oral health in patients infected with the human immunodeficiency virus

  2023cites this paper
• Analgesic Efficacy of Curcuma longa (Curcumin) after Surgical Periodontal Therapy

  2022cites this paper
• Effect of non-surgical periodontal therapy on clinical parameters of periodontitis, Candida spp. count and lactoferrin and histatin-5 expression in saliva and ginvival crevicular fluid of HIV-infected patients.

  2022cites this paper
• Oral Cells-On-Chip: Design, Modeling and Experimental Results

  2022cites this paper
• Immune markers and microbial factors are related with periodontitis severity in people with HIV

  2022cites this paper
• Oral Manifestations Associated with HIV/AIDS Patients

  2022cites this paper
• The Expression of miR-34a in Gingival Crevicular Fluid of Chronic Periodontitis and Its Connection with the TLR/NF-κB Signaling Pathway

  2022cites this paper
• In vitro Azole antifungals susceptibility of Candida spp. isolates from HIV-infected patients with periodontitis.

  2022cites this paper
• In silico evaluation of atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs

  2022cites this paper
• Stage II and stage III periodontitis clinical burdens of HIV-1 undergoing antiretroviral therapy

  2021cites this paper
• Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome

  2021cites this paper
• Envisaging Antifungal Potential of Histatin 5: A Physiological Salivary Peptide

  2021cites this paper
• Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions

  2021cites this paper
• Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses

  2021cites this paper
• Quantification of pathogenic bacteria in the subgingival oral biofilm samples collected from cigarette-smokers, individuals using electronic nicotine delivery systems and non-smokers with and without periodontitis.

  2020cites this paper
• Interleukin 35 levels in saliva of type 2 diabetic patients with moderate chronic periodontitis

  2020cites this paper
• Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques

  2020cites this paper
• Severe periodontitis is more common in HIV- infected patients.

  2019cites this paper
• Immune System-Related Diseases and Dental Implant Treatment

  2019cites this paper
• Microbiological study of the subgingival biofilm in HIV+/HAART patients at a specialized dental service.

  2019cites this paper
• Management of periodontal disease

  2018cites this paper
• Effects of periodontal treatment on serum inflammatory markers and cd4t-lymphocyte cell count in patients with human immunodeficiency virus infection

  2018cites this paper